Pediatrix Medical Group, Inc. - 10-Q Summary (Q1 2000)
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2000. Pediatrix Medical Group, Inc. operates as a provider of neonatal and pediatric medical services. During the quarter, the Company completed the acquisition of two physician group practices for approximately $7.6 million in cash.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Net Patient Service Revenue | $59.4 million | $53.8 million |
| Income from Operations | $7.0 million | $12.2 million |
| Net Income | $3.4 million | $7.3 million |
| Diluted EPS | $0.22 | $0.45 |
| Operating Cash Flow | $5.3 million | $10.5 million |
| Cash and Equivalents (End of Period) | $1.1 million | $0.6 million |
| Line of Credit Outstanding | $52.1 million | N/A |
| Working Capital | ($18.4 million) deficit | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 10.4% year-over-year, driven by new units from acquisitions. However, same-unit revenue declined 7.8% due to lower patient acuity levels.
- Expense Increases: Salaries and benefits rose 25.9% ($8.9 million) due to hiring for new units and increased support staff. Supplies and other operating expenses increased 26.4%, partly due to legal fees related to government investigations and headquarters relocation.
- Profitability Decline: Net income dropped 53.4% to $3.4 million. Operating income fell 42.4% to $7.0 million. The effective tax rate increased from 40% to 45% due to non-deductible goodwill amortization.
- Liquidity Position: The Company reported a working capital deficit of $18.4 million, primarily due to the classification of its $52.1 million line of credit as a current liability. Net cash used in investing activities was $8.7 million, largely for acquisitions.
Outlook, Risks, and Contingencies
- Financing Needs: The Company's $75 million line of credit matures on September 30, 2000. Management is evaluating options for refinancing but noted no assurance that similar terms can be secured.
- Legal Proceedings: A consolidated federal securities class action lawsuit is pending, alleging violations regarding accounting practices and revenue recognition. The Company intends to defend vigorously. Additionally, state investigators in Arizona, Colorado, and Florida are reviewing the Company's billing practices; the outcome is uncertain.
- Market Risk: The Company has approximately $71.2 million in variable-rate debt and leases. A 1% change in interest rates would impact pre-tax earnings by approximately $712,000 annually.
Investor Verification Checklist
- Verify the status and potential financial impact of the ongoing federal securities class action lawsuit and state billing investigations.
- Confirm the Company's ability to refinance its $52.1 million line of credit prior to the September 30, 2000 maturity date.
- Monitor the trend in same-unit revenue, which declined 7.8% due to lower patient acuity, to assess organic growth sustainability.
- Review the composition of the working capital deficit and the Company's cash burn rate relative to operating cash flow.